This book starts from the clinical reality, take practicality as the purpose, closely integrate clinical work, including important clinical therapeutic regimens for various cancer, and describes the new developments in treatment of common malignant tumors. At the same time, in combination with improved version of the ASCO value framework, systematic and standardized comparisons and in-depth evaluations of therapeutic regimens were made to promote the standardization of medical treatment decisions for malignant tumors.  Compared with the traditional evaluation method of malignant tumor therapeutic regimens, the evaluation method of this book has outstanding advantages. First, the evaluation indicators are comprehensive and diverse. The evaluation includes multiple indicators such as clinical benefits, adverse reactions, additional benefits, and costs, and includes more effective evaluation indicators to comprehensively evaluate the treatment plan.